Clinical Trial Update: A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing alendronate and risedronate to assess their effects on bone mineral density in postmenopausal osteoporosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• alendronate (alendronate)
• risedronate (risedronate)

Snippet

Sponsor: Organon and Co | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: COMPLETED